These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36714575)

  • 1. Probiotic induced synthesis of microbiota polyamine as a nutraceutical for metabolic syndrome and obesity-related type 2 diabetes.
    Bui TI; Britt EA; Muthukrishnan G; Gill SR
    Front Endocrinol (Lausanne); 2022; 13():1094258. PubMed ID: 36714575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity.
    Bui TI; Gill AL; Mooney RA; Gill SR
    Microbiol Spectr; 2022 Apr; 10(2):e0017022. PubMed ID: 35315698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases.
    Ramos-Molina B; Queipo-Ortuño MI; Lambertos A; Tinahones FJ; Peñafiel R
    Front Nutr; 2019; 6():24. PubMed ID: 30923709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut microbiota in mediating obesity and diabetes mellitus.
    Pitocco D; Di Leo M; Tartaglione L; De Leva F; Petruzziello C; Saviano A; Pontecorvi A; Ojetti V
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1548-1562. PubMed ID: 32096204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
    Aydin Ö; Nieuwdorp M; Gerdes V
    Curr Diab Rep; 2018 Jun; 18(8):55. PubMed ID: 29931613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases.
    Zeng Y; Wu Y; Zhang Q; Xiao X
    mBio; 2024 Jan; 15(1):e0203223. PubMed ID: 38055342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome.
    Guimarães VHD; Marinho BM; Motta-Santos D; Mendes GDRL; Santos SHS
    J Nutr Biochem; 2023 Mar; 113():109252. PubMed ID: 36509338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.